Submitted by elizabethwu1 on Thu, 07/21/2016 - 3:51pm NCT02670083 Crenezumab United States Tuesday, March 1, 2016 – Saturday, July 31, 2021 750 Phase 3 Alzheimer's Disease Thursday, July 21, 2016 Hoffmann-La Roche Comments No Available Comments Make a Comment To make a comment you must login or register.
Submitted by elizabethwu1 on
Submitted by elizabethwu1 on
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.